Loading…
Hosted by Unknown Host · 🇺🇸 US · EN · 257 episodes
Established thought leaders with verified media credentials.
Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing.In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides.Make sure to subscribe for your regular dose of pharma insight.
Unknown Host hosts PharmaSource Podcast, a science show with 257 episodes published.
“When we go to an external partner, we need to show up as one single aligned organization. If we’re not aligned internally, the CMO ends up becoming the referee.” In pharmaceutical manufacturing, the quality of a CDMO pa
When relationships with contract manufacturers break down, the cause is rarely just the contract manufacturer. A panel of three sponsor-side executives examined the warning signs, the internal failures, and the governanc
“The least expensive CDMO on the first day of bidding may not be the optimum value CDMO three years later.” Choosing a contract development and manufacturing organization is not about who quotes the lowest unit price. It
At CDMO Live Europe, Dr. Vijay Vittal Mathad , Chief Operating Officer of CRAMSN Research Park, outlined how a genuine end-to-end CDMO model reduces friction across the drug development lifecycle, from supply chain resil
Leon Tian , Director of US Project Management, ProBio, walked through the cell line development, high-concentration formulation, and purification workflow, delivering a bispecific antibody tox batch from a single selecte
“Environmental Sustainability can be a substantial differentiator for CDMOs” Jürgen Wieland , Development Environmental Sustainability Lead at Novartis, is engaged to integrate sustainability into development processes,
At CDMO Live Europe 2026, a panel of pharma and CDMO executives examined how supply chains must be redesigned for a world of sustained geopolitical pressure, regulatory fragmentation, and accelerating demand, and where c
“Projects quite often realize too late that their R&D process cannot just be copy-pasted from the lab into the manufacturing facility.” Dr. Jenny Prange is Head of Project Management at the Regenerative Medicine Technolo
Andrzej Hoczyk, External Supply Operations (ESO) Head at Polpharma, presented the case for treating large-scale tech transfer as a managed program rather than a series of parallel projects at CDMO Live Europe 2026, drawi
"The quality of any relationship becomes most visible during times of challenge and pressure," says Frederik Krekeler . Frederik Krekeler is Head of Procurement for Bayer's Consumer Health business in North America, lead
At CDMO Live Europe 2026, Dr. Adriana Kiedzierska-Mencfeld , Chief Executive Officer of Rezon Bio, drew on 11 years of leading operations at Polpharma Biologics to explain why biosimilar developers must address cost stra
“CMC was not usually a core part of the planning — it was more of an afterthought. Now that funding has tightened, that is changing.” Siddhartha Jain, President of Shoolin Management Company, has spent two decades in bio
At CDMO Live Europe 2025, a panel of procurement and commercial leaders argued that the most consequential CDMO negotiations happen after the contract is signed, covering risk-sharing structures, governance discipline, a
Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA), walked CDMO Live Europe delegates through the full matrix of US policy pressures bearing on contract manufacturers, from Section 232 tariffs a
At CDMO Live Europe 2026 Maik Talarczyk Head PMO External Supplier Operations, Sandoz, laid out the company’s three-year supplier network consolidation program, detailing a six-step make-vs-buy decision framework that re
"We saw what you guys built and made a decision pretty quickly: we didn't want to compete with that. We wanted to be part of it." Jon Howland, CEO, Life Science Connect Today we are announcing that PharmaSource, CDMO Liv
Mike Schaefers, Chief Operating Officer at Simtra BioPharma, outlined what it takes to build durable CDMO partnerships in injectable manufacturing, why regional supply chains have become a permanent feature, and how earl
"The challenge is not getting better biology. It's building a better system to carry the biology forward," says Richard van Rijnsoever. Debby Vermeer and Richard van Rijnsoever are co-founders of ExpediteBio, a Netherlan
“When your patient is your priority—getting them safe, highly pure, quality medicine—you’re aligned with the health agency. That alignment and engagement really help.” Manda Pasarkar , Global Head of Regulatory Affairs C
A panel discussion with Cristoffer Frendesen, EU Correspondent at Dagens Pharma, and Gil Roth, President of the Pharma and Biopharma Outsourcing Association, at CDMO Live Europe 2026, examined how US pricing policy, Euro
Matt Lowe
West Coast Account Manager · Superfici America
1 appearance on this show
David Cox
author of This Is A Gun: A Safety Guide for Families with Children · Financially INsync at Raymond James Ltd in Canada
1 appearance on this show
Ryan Kelly
Interim CEO and Senior Director of Supply Chain Security and Brand Protection · Association For Manufacturing Technology’s San Francisco Tech Lab
1 appearance on this show
Dr. Adriana Kiedzierska-Mencfeld
Rezon Bio
1 appearance on this show
Siddhartha Jain
Shoolin Management Company
1 appearance on this show
Gil Roth
Pharma and Biopharma Outsourcing Association
1 appearance on this show
Cristoffer Frendesen
Dagens Pharma
1 appearance on this show
Krish Ramanathan
Gates Medical Research Institute
1 appearance on this show
Christopher Locher
Versatope Therapeutics
1 appearance on this show
Savant Ahmed
Exela Pharma Sciences
1 appearance on this show
Kristopher Howard
NRL Enterprise Solutions
1 appearance on this show
Christian Seufert
Lonza
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
PharmaSource Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
PharmaSource Podcast is hosted by Unknown Host. The show is categorised under science (life) and has published 257 episodes.
PharmaSource Podcast has published 257 episodes.
PharmaSource Podcast regularly covers science, life. It sits in the science category, with a life focus.
PharmaSource Podcast is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
PharmaSource Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of PharmaSource Podcast average 28 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates PharmaSource Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 6 days ago.